Prevalence of Heart Failure and Adherence to Process Indicators: Which Socio-Demographic Determinants are Involved?

International Journal of Environmental Research and Public Health
Alessandra BujaGianfranco Damiani

Abstract

Interest in chronic conditions reflects their role as the first cause of death and disability in developed countries; improving the management of these conditions is a priority for health care services. The aim of this study was to establish which sociodemographic factors influence adherence to standards of care for chronic heart failure (CHF). A generalized multilevel structural equation model was developed and applied to a sample of patients with CHF obtained from administrative data flows in six Italian regions to ascertain any associations between adherence to standards of care for CHF and sociodemographic variables. Indicators of compliance were adherence to beta-blocker therapy (BB-A) and Angiotensin Convertin Enzime inhibitor/Angiotensin Receptor Blocker therapy (ACE-A), and creatinine and electrolyte testing (CNK-T). All indicators were computed over a one-year follow-up. Among a cohort of 24,997 patients, the BB-A rate was 40.4%, the ACE-A rate 61.1%, and the CNK-T rate 57.0%. Factors found associated with adherence were gender, age, and citizenship. Our study shows an inadequate adherence to standards of care for CHF, particularly associated with certain sociodemographic characteristics. This suggests the need to impr...Continue Reading

References

Aug 9, 2002·European Journal of Heart Failure·Fátima CeiaUNKNOWN EPICA Investigators
Jan 9, 2003·JAMA : the Journal of the American Medical Association·Margaret M RedfieldRichard J Rodeheffer
Dec 12, 2003·European Journal of Cardiovascular Nursing : Journal of the Working Group on Cardiovascular Nursing of the European Society of Cardiology·Sabina De Geest, Eduardo Sabaté
Apr 15, 2006·Heart·P A Mehta, M R Cowie
Jul 11, 2006·The American Journal of Medicine·Mikhail KosiborodHarlan M Krumholz
Jul 16, 2008·Journal of Clinical Epidemiology·Mary E CharlsonJames P Hollenberg
May 24, 2011·Cardiovascular Therapeutics·Lutz FrankensteinJorge P Ribeiro
Oct 14, 2011·Kidney International·William G CouserMarcello Tonelli
Sep 25, 2012·The European Journal of General Practice·Maurizio CancianRoberto Toffanin
Apr 20, 2013·Current Cardiology Reviews·K Guha, T McDonagh
Jun 12, 2013·Journal of the American College of Cardiology·Clyde W YancyUNKNOWN American Heart Association Task Force on Practice Guidelines
Dec 25, 2013·Journal of General Internal Medicine·Yuting Zhang, Seo Hyon Baik
Jul 12, 2014·BMC Endocrine Disorders·Alessandra BujaMariadonata Bellentani
Jan 27, 2015·Journal of Cardiopulmonary Rehabilitation and Prevention·Noriko EndoSeiji Yasumura
Feb 12, 2015·Archives of public health = Archives belges de santé publique·Tim MathesDawid Pieper
May 20, 2015·Pharmacoepidemiology and Drug Safety·Beatrice A MarzlufMichael Wolzt
Jun 4, 2015·Professional Case Management·Marisa A Bisiani, Corinne Y Jurgens

❮ Previous
Next ❯

Citations

Feb 6, 2017·Contemporary Nurse·Mehnosh Toback, Nancy Clark
Mar 31, 2018·Pharmacotherapy·Sarah R HoodMichael D Murray
Jun 3, 2020·European Journal of Heart Failure·Amy GroenewegenArno W Hoes
Jul 18, 2020·Cardiology Research and Practice·Silvia RomitiErnesto Greco
Feb 9, 2017·Current Heart Failure Reports·Hernando Vargas-Uricoechea, Anilza Bonelo-Perdomo
Nov 21, 2018·International Journal for Equity in Health·Gianluca CafagnaSabina Nuti
Jan 22, 2022·The Egyptian Heart Journal : (EHJ) : Official Bulletin of the Egyptian Society of Cardiology·Vaishak KaviarasanRamakrishnan Veerabathiran

❮ Previous
Next ❯

Software Mentioned

Stata
VALORE

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.